or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Mercy Health Center

    Trial Locations
    Mercy Health Center
    Central Oklahoma Cancer Center at INTEGRIS Southwest Medical Center
    Breast Cancer
    S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Melanoma (Skin), Metastatic Cancer
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Oklahoma University Medical Center

    Trial Locations
    Oklahoma University Medical Center
    Frank C. Love Cancer Institute at St. Anthony Hospital
    Lung Cancer
    S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lung Cancer
    S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Esophageal Cancer, Gastric Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Anemia, Head and Neck Cancer
    Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Leukemia
    Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Endometrial Cancer
    Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Head and Neck Cancer
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    Veterans Affairs Medical Center - Oklahoma City

    Trial Locations
    Veterans Affairs Medical Center - Oklahoma City
    University of Oklahoma Health Sciences Center
    Gastrointestinal Stromal Tumor
    S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Multiple Myeloma
    Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    Oklahoma Memorial Hospital
    Oklahoma City, Oklahoma 73126-0307
    Leukemia, Lymphoma
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    Veterans Affairs Medical Center - Oklahoma City

    Trial Locations
    Veterans Affairs Medical Center - Oklahoma City
    University of Oklahoma Health Sciences Center
    Leukemia
    Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Vulvar Cancer
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Children's Hospital of Oklahoma
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Lung Cancer
    S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Veterans Affairs Medical Center - Oklahoma City

    Trial Locations
    Veterans Affairs Medical Center - Oklahoma City
    University of Oklahoma Health Sciences Center
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Prostate Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Colorectal Cancer
    Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Lung Cancer
    Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lung Cancer
    S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lymphoma
    Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer